Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03524521 · ClinicalTrials.gov registry record · NA

Body Weight-Based Interval Training in Sedentary Overweight and Obese Adults

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
22
Enrollment target

NCT03524521: Completed NA study, sponsored by Mayo Clinic.

NCT03524521 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03524521, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target

Study Summary

Body-weight based interval training (IT) performed 3 times per week will lead to reductions in abdominal adiposity and reduce overall body fat percentage in overweight and obese sedentary adults more effectively than moderate intensity continuous training (MICT). Body-weight interval training will improve exercise capacity (peak VO2) in overweight/obese adults.

Primary Outcome

DEXA derived body fat %

Interventions

  • BEHAVIORAL Standard of Care
  • BEHAVIORAL Interval Training

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2018-11-06
Est. Completion 2021-01-08
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT03524521 record still lists

NCT03524521 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.

NCT03524521 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03524521 about?

NCT03524521 is a clinical study titled "Body Weight-Based Interval Training in Sedentary Overweight and Obese Adults". Body-weight based interval training (IT) performed 3 times per week will lead to reductions in abdominal adiposity and reduce overall body fat percentage in overweight and obese sedentary adults more effectively than moderate intensity continuous training (MICT). Body-weight interval training will i...

What is the current status of trial NCT03524521?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2018-11-06. Estimated completion is 2021-01-08.

What interventions are being tested in trial NCT03524521?

The interventions under investigation include: Standard of Care (BEHAVIORAL), Interval Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT03524521?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03524521's enrollment target sits among peer trials

22 1756th of 2000 higher than 239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03524521, the US trial registry maintained by the National Library of Medicine. NCT03524521 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.